NOV 25, 2018 7:26 PM PST

Advancing Drug Therapies for an Increasing Case of a Parasitic infection Among Displaced Syrians

WRITTEN BY: Nouran Amin

Cases of Cutaneous leishmaniasis (CL), a parasitic disease, has increased dramatically in Syria and neighboring countries as a result of the conflict-related displacement of Syrians.

Drawing depicting family feeling war-torn Syria.

Credit: Jan Birck via Public International Radio (PRI.org)

Now, a recent study published in PLOS Neglected Tropical Diseases by Rana El Hajj at the American University of Beirut, Lebanon describes the development of a novel immunomodulatory analog that will seek to advance the treatment of CL.

Cutaneous leishmaniasis (CL) is a parasitic infection with occurrences throughout the Americas from Texas to Argentina, and in the Old World, particularly the Middle East and North Africa. The infection is spread via by a female sandfly and is diagnosed annually in travelers, immigrants, and military personnel. Health care providers in the United States must alert to the diagnosis of leishmaniasis in travelers flying from endemic areas.

Presently, current therapeutics for CL can induce partial or complete cure. But these therapies come with multiple limitations, such as repetitive painful administrations, lack of availability, increased cost, and the emergence of resistant strains. Most importantly, the efficacy of these therapies are effected by the patient's age and immune system.

Learn more about Cutaneous leishmaniasis (CL):

In the study, the pre-clinical efficacy of the immunomodulatory drug--Imiquimod and one of its analogs, EAPB0503--on two strains (Leishmania major and Leishmania tropica) were investigated. These strains are known to cause CL in regions of the Middle East. These drugs were also tested on freshly isolated parasites from biopsies that proved their leishmanicidal potency.

The authors note, "Our findings establish Imiquimod as a strong candidate for treating L. tropica and show the higher potency of its analog EAPB0503 against CL."

The study is a promising solution to a current global health crisis and will effectively combat the increasing cases of CL.

Source: American Family Physician, PLOS Neglected Tropical Diseases

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 03, 2020
Cannabis Sciences
Cannabis Compound Prevents Colon Cancer in Mice
OCT 03, 2020
Cannabis Compound Prevents Colon Cancer in Mice
Second only to skin cancer, colon cancer is the most common cancer diagnosed in both men and women in the US. Now, resea ...
OCT 05, 2020
Drug Discovery & Development
Fecal Transplants Could Restore Cognitive Function in the Elderly
OCT 05, 2020
Fecal Transplants Could Restore Cognitive Function in the Elderly
An international team of researchers has found that fecal transplants could one day be used to restore cognitive functio ...
OCT 23, 2020
Drug Discovery & Development
Common Asthmatic Treatments Increase Risk of Bone Fractures
OCT 23, 2020
Common Asthmatic Treatments Increase Risk of Bone Fractures
A study published in the journal Thorax found that taking steroid inhalers or tablets for asthma treatment to control fl ...
NOV 02, 2020
Cancer
Using an Anti-Malarial Drug to Fight Cancer
NOV 02, 2020
Using an Anti-Malarial Drug to Fight Cancer
Modern pharmaceutical companies spend billions of dollars and years of time developing the next big drug. What if they d ...
NOV 05, 2020
Immunology
Awakening Ancient DNA to Kill Cancer
NOV 05, 2020
Awakening Ancient DNA to Kill Cancer
In a recent study published in Nature, scientists from the University of Toronto described the discovery of ancient DNA ...
NOV 26, 2020
Immunology
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
NOV 26, 2020
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
  There’s a new weapon in the battle against lung cancer metastases: red blood cells equipped with nanopartic ...
Loading Comments...